Cargando…
Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections—A Scandinavian real-life study
BACKGROUND AND AIMS: Chronic hepatitis C virus (HCV) genotype 3 infection with advanced liver disease has emerged as the most challenging to treat. We retrospectively assessed the treatment outcome of sofosbuvir (SOF) based regimes for treatment of HCV genotype 3 infections in a real life setting in...
Autores principales: | Dalgard, Olav, Weiland, Ola, Noraberg, Geir, Karlsen, Lars, Heggelund, Lars, Färkkilâ, Martti, Balslev, Ulla, Belard, Erika, Øvrehus, Anne, Skalshøi Kjær, Mette, Krarup, Henrik, Thorup Røge, Birgit, Hallager, Sofie, Madsen, Lone G., Lund Laursen, Alex, Lagging, Martin, Weis, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509146/ https://www.ncbi.nlm.nih.gov/pubmed/28704381 http://dx.doi.org/10.1371/journal.pone.0179764 |
Ejemplares similares
-
Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response
por: Hallager, Sofie, et al.
Publicado: (2017) -
Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population
por: Bollerup, Signe, et al.
Publicado: (2022) -
The Prevalence of Human Immunodeficiency Virus Coinfection Among Patients Newly Diagnosed With Chronic Hepatitis B or C in Denmark: A Nationwide Cohort Study
por: Hallager, Sofie, et al.
Publicado: (2018) -
Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection
por: Waldenström, Jesper, et al.
Publicado: (2016) -
Late Presentation for Care Among Patients With Chronic Hepatitis C: Prevalence and Risk Factors
por: Hansen, Janne Fuglsang, et al.
Publicado: (2017)